Now PlayingEP. 1 Vitiligo Management Strategies: A Case-Based Discussion on Treatment Challenges and Solutions
EP. 2 Community Physician Voices: Exploring Management Options for a 50-Year-Old Patient with Vitiligo
Noninvasive Imaging Maps Repigmentation and Melanocyte Activation in Ruxolitinib-Treated VitiligoByMarie Bosslett, Assistant EditorAugust 24th 2026
Meta-Analysis Finds Significantly Lower SCC Risk in Patients With VitiligoByMarie Bosslett, Assistant EditorAugust 20th 2026
How to Explain JAK Inhibitor Safety to PatientsByLisa Swanson, MD, FAAD,Shannon Heaning, Content AssociateJuly 31st 2026
Ritlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo TrialsByKaitlyn Bader, Assistant Managing EditorJuly 30th 2026